Introduction: Breast cancer is a major public health issue in Brazil, with high mortality rates, particularly among women in socially vulnerable conditions. In the Legal Amazon, regional inequalities and low educational levels hinder access to information, screening, and early diagnosis of the disease. Objective: To analyze the epidemiological profile of breast cancer mortality among women with low educational levels in the Legal Amazon between 2018 and 2023, aiming to identify socioeconomic and demographic patterns associated with these deaths. Methods: This is a descriptive, population-based study with a quantitative approach, using secondary data from the Mortality Information System (SIM), accessed via TABNET/DATASUS. Included were deaths of women aged 10 to 49 years, residing in the states of the Legal Amazon, with a diagnosis of malignant neoplasm of the breast (ICD-10: C50) and educational attainment of 1 to 7 years of schooling. Results: A total of 168 deaths were identified among women with low educational levels. Most were single (n=103; 61.3%) and had 4 to 7 years of schooling (n=125; 74.4%). The metropolitan regions of Belém (PA) and Manaus (AM) accounted for 56.5% of deaths (n=95), indicating that mortality remains high even in areas with greater healthcare service availability. Other municipalities such as Macapá (AP), Santarém (PA), and the Rio Cuiabá Valley (MT) also reported deaths, suggesting that mortality extends beyond major urban centers. Although a slightly higher educational level may offer partial protection, it remains insufficient to reverse adverse outcomes. Conclusion: The findings indicate that breast cancer remains a significant cause of mortality among young women with low educational levels in the Legal Amazon. The predominance of deaths among single women and those with up to seven years of education highlights the impact of social and structural inequalities on health outcomes. The concentration of deaths in urban capitals and the presence of cases in under-resourced areas underscore the need to strengthen early detection efforts, health education, and regionalized oncological care to mitigate the impact of this condition on vulnerable populations in the Amazon region.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
